Please login to the form below

Not currently logged in

Dr Angelika Bodenteich joins Marinomed Biotechnologie

Dr Angelika Bodenteich takes up a role as head of development at the Austrian biotech company

Dr Angelika Bodenteich has been appointed head of development at Austrian company Marinomed Biotechnologie GmbH, which develops innovative therapies for respiratory diseases.

She joins from Onepharm Research & Development, where she held the positions of chief medical officer and head of development.

Prior to this she spent four years at Sanochemia Pharmazeutika as head of research & development, where she was responsible for both pharmaceutical and business development.

Dr Andreas Grassauer, CEO and co-founder of Marinomed, said: “We are delighted to welcome Angelika to the team - her scientific and professional expertise in the area of research and development as well as her experience in international collaborations and business development will certainly be a significant addition to Marinomed as we work to further develop our pipeline.”

Dr Bodenteich has more than 15 years of experience in the pharmaceutical industry and is a trained pathologist who has held positions in research and industry in Austria, Norway and the US.

3rd November 2011


Featured jobs

Subscribe to our email news alerts


Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...